img

Global Swine Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Swine Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
Swine Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Swine Vaccines market is projected to reach US$ 1820.9 million in 2034, increasing from US$ 1379.2 million in 2022, with the CAGR of 4.0% during the period of 2024 to 2034. Demand from Government Tender and Market Sales are the major drivers for the industry.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Swine Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Others

Segment by Application


Government Tender
Market Sales

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Swine Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Swine Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Swine Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Swine Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Swine Vaccines introduction, etc. Swine Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Swine Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Swine Vaccines Market Overview
1.1 Swine Vaccines Product Overview
1.2 Swine Vaccines Market Segment by Type
1.2.1 CSF Vaccines
1.2.2 FMD Vaccines
1.2.3 Porcine Circovirus Vaccines
1.2.4 PRRS Vaccines
1.2.5 Others
1.3 Global Swine Vaccines Market Size by Type
1.3.1 Global Swine Vaccines Market Size Overview by Type (2018-2034)
1.3.2 Global Swine Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Swine Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Swine Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Swine Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Swine Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Swine Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Swine Vaccines Sales Breakdown by Type (2018-2024)
2 Global Swine Vaccines Market Competition by Company
2.1 Global Top Players by Swine Vaccines Sales (2018-2024)
2.2 Global Top Players by Swine Vaccines Revenue (2018-2024)
2.3 Global Top Players by Swine Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Swine Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Swine Vaccines Market Competitive Situation and Trends
2.5.1 Swine Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Swine Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swine Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Swine Vaccines Market
2.8 Key Manufacturers Swine Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Swine Vaccines Status and Outlook by Region
3.1 Global Swine Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Swine Vaccines Historic Market Size by Region
3.2.1 Global Swine Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Swine Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Swine Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Swine Vaccines Forecasted Market Size by Region
3.3.1 Global Swine Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Swine Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Swine Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Swine Vaccines by Application
4.1 Swine Vaccines Market Segment by Application
4.1.1 Government Tender
4.1.2 Market Sales
4.2 Global Swine Vaccines Market Size by Application
4.2.1 Global Swine Vaccines Market Size Overview by Application (2018-2034)
4.2.2 Global Swine Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Swine Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Swine Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Swine Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Swine Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Swine Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Swine Vaccines Sales Breakdown by Application (2018-2024)
5 North America Swine Vaccines by Country
5.1 North America Swine Vaccines Historic Market Size by Country
5.1.1 North America Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Swine Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Swine Vaccines Sales in Value by Country (2018-2024)
5.2 North America Swine Vaccines Forecasted Market Size by Country
5.2.1 North America Swine Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Swine Vaccines Sales in Value by Country (2024-2034)
6 Europe Swine Vaccines by Country
6.1 Europe Swine Vaccines Historic Market Size by Country
6.1.1 Europe Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Swine Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Swine Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Swine Vaccines Forecasted Market Size by Country
6.2.1 Europe Swine Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Swine Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Swine Vaccines by Region
7.1 Asia-Pacific Swine Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Swine Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Swine Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Swine Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Swine Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Swine Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Swine Vaccines Sales in Value by Region (2024-2034)
8 Latin America Swine Vaccines by Country
8.1 Latin America Swine Vaccines Historic Market Size by Country
8.1.1 Latin America Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Swine Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Swine Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Swine Vaccines Forecasted Market Size by Country
8.2.1 Latin America Swine Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Swine Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Swine Vaccines by Country
9.1 Middle East and Africa Swine Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Swine Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Swine Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Swine Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Swine Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Swine Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck Swine Vaccines Products Offered
10.1.5 Merck Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Introduction and Business Overview
10.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Boehringer Ingelheim Swine Vaccines Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 Jinyu Bio-Technology
10.3.1 Jinyu Bio-Technology Company Information
10.3.2 Jinyu Bio-Technology Introduction and Business Overview
10.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Jinyu Bio-Technology Swine Vaccines Products Offered
10.3.5 Jinyu Bio-Technology Recent Development
10.4 CAHIC
10.4.1 CAHIC Company Information
10.4.2 CAHIC Introduction and Business Overview
10.4.3 CAHIC Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 CAHIC Swine Vaccines Products Offered
10.4.5 CAHIC Recent Development
10.5 Tecon
10.5.1 Tecon Company Information
10.5.2 Tecon Introduction and Business Overview
10.5.3 Tecon Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Tecon Swine Vaccines Products Offered
10.5.5 Tecon Recent Development
10.6 Zoetis
10.6.1 Zoetis Company Information
10.6.2 Zoetis Introduction and Business Overview
10.6.3 Zoetis Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Zoetis Swine Vaccines Products Offered
10.6.5 Zoetis Recent Development
10.7 Ceva
10.7.1 Ceva Company Information
10.7.2 Ceva Introduction and Business Overview
10.7.3 Ceva Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Ceva Swine Vaccines Products Offered
10.7.5 Ceva Recent Development
10.8 Hile Bio
10.8.1 Hile Bio Company Information
10.8.2 Hile Bio Introduction and Business Overview
10.8.3 Hile Bio Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Hile Bio Swine Vaccines Products Offered
10.8.5 Hile Bio Recent Development
10.9 Chopper Biology
10.9.1 Chopper Biology Company Information
10.9.2 Chopper Biology Introduction and Business Overview
10.9.3 Chopper Biology Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Chopper Biology Swine Vaccines Products Offered
10.9.5 Chopper Biology Recent Development
10.10 WINSUN
10.10.1 WINSUN Company Information
10.10.2 WINSUN Introduction and Business Overview
10.10.3 WINSUN Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.10.4 WINSUN Swine Vaccines Products Offered
10.10.5 WINSUN Recent Development
10.11 Hipra
10.11.1 Hipra Company Information
10.11.2 Hipra Introduction and Business Overview
10.11.3 Hipra Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Hipra Swine Vaccines Products Offered
10.11.5 Hipra Recent Development
10.12 Ringpu Biology
10.12.1 Ringpu Biology Company Information
10.12.2 Ringpu Biology Introduction and Business Overview
10.12.3 Ringpu Biology Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Ringpu Biology Swine Vaccines Products Offered
10.12.5 Ringpu Biology Recent Development
10.13 ChengDu Tecbond
10.13.1 ChengDu Tecbond Company Information
10.13.2 ChengDu Tecbond Introduction and Business Overview
10.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.13.4 ChengDu Tecbond Swine Vaccines Products Offered
10.13.5 ChengDu Tecbond Recent Development
10.14 DHN
10.14.1 DHN Company Information
10.14.2 DHN Introduction and Business Overview
10.14.3 DHN Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.14.4 DHN Swine Vaccines Products Offered
10.14.5 DHN Recent Development
10.15 CAVAC
10.15.1 CAVAC Company Information
10.15.2 CAVAC Introduction and Business Overview
10.15.3 CAVAC Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.15.4 CAVAC Swine Vaccines Products Offered
10.15.5 CAVAC Recent Development
10.16 Virbac
10.16.1 Virbac Company Information
10.16.2 Virbac Introduction and Business Overview
10.16.3 Virbac Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Virbac Swine Vaccines Products Offered
10.16.5 Virbac Recent Development
10.17 HVRI
10.17.1 HVRI Company Information
10.17.2 HVRI Introduction and Business Overview
10.17.3 HVRI Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.17.4 HVRI Swine Vaccines Products Offered
10.17.5 HVRI Recent Development
10.18 Bioveta
10.18.1 Bioveta Company Information
10.18.2 Bioveta Introduction and Business Overview
10.18.3 Bioveta Swine Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Bioveta Swine Vaccines Products Offered
10.18.5 Bioveta Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Swine Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Swine Vaccines Industrial Chain Analysis
11.4 Swine Vaccines Market Dynamics
11.4.1 Swine Vaccines Industry Trends
11.4.2 Swine Vaccines Market Drivers
11.4.3 Swine Vaccines Market Challenges
11.4.4 Swine Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Swine Vaccines Distributors
12.3 Swine Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of CSF Vaccines
Table 2. Major Company of FMD Vaccines
Table 3. Major Company of Porcine Circovirus Vaccines
Table 4. Major Company of PRRS Vaccines
Table 5. Major Company of Others
Table 6. Global Swine Vaccines Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Swine Vaccines Sales by Type (2018-2024) & (M Doses)
Table 8. Global Swine Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Swine Vaccines Sales by Type (2018-2024) & (US& Million)
Table 10. Global Swine Vaccines Market Share in Value by Type (2018-2024)
Table 11. Global Swine Vaccines Price by Type (2018-2024) & (USD/K Doses)
Table 12. Global Swine Vaccines Sales by Type (2024-2034) & (M Doses)
Table 13. Global Swine Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Swine Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Swine Vaccines Sales Market Share in Value by Type (2024-2034)
Table 16. Global Swine Vaccines Price by Type (2024-2034) & (USD/K Doses)
Table 17. North America Swine Vaccines Sales by Type (2018-2024) & (M Doses)
Table 18. North America Swine Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Swine Vaccines Sales (M Doses) by Type (2018-2024)
Table 20. Europe Swine Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Swine Vaccines Sales (M Doses) by Type (2018-2024)
Table 22. Asia-Pacific Swine Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Swine Vaccines Sales (M Doses) by Type (2018-2024)
Table 24. Latin America Swine Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Swine Vaccines Sales (M Doses) by Type (2018-2024)
Table 26. Middle East and Africa Swine Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Swine Vaccines Sales by Company (2018-2024) & (M Doses)
Table 28. Global Swine Vaccines Sales Share by Company (2018-2024)
Table 29. Global Swine Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Swine Vaccines Revenue Share by Company (2018-2024)
Table 31. Global Market Swine Vaccines Price by Company (2018-2024) & (USD/K Doses)
Table 32. Global Swine Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Swine Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swine Vaccines as of 2022)
Table 35. Date of Key Manufacturers Enter into Swine Vaccines Market
Table 36. Key Manufacturers Swine Vaccines Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Swine Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Swine Vaccines Sales by Region (2018-2024) & (M Doses)
Table 40. Global Swine Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Swine Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Swine Vaccines Sales Market Share in Value by Region (2018-2024)
Table 43. Global Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 44. Global Swine Vaccines Sales by Region (2024-2034) & (M Doses)
Table 45. Global Swine Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Swine Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Swine Vaccines Sales Market Share in Value by Region (2024-2034)
Table 48. Global Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2024-2034)
Table 49. Global Swine Vaccines Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Swine Vaccines Sales by Application (2018-2024) & (M Doses)
Table 51. Global Swine Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Swine Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Swine Vaccines Sales Market Share in Value by Application (2018-2024)
Table 54. Global Swine Vaccines Price by Application (2018-2024) & (USD/K Doses)
Table 55. Global Swine Vaccines Sales by Application (2024-2034) & (M Doses)
Table 56. Global Swine Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Swine Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Swine Vaccines Sales Market Share in Value by Application (2024-2034)
Table 59. Global Swine Vaccines Price by Application (2024-2034) & (USD/K Doses)
Table 60. North America Swine Vaccines Sales by Application (2018-2024) (M Doses)
Table 61. North America Swine Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Swine Vaccines Sales by Application (2018-2024) (M Doses)
Table 63. Europe Swine Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Swine Vaccines Sales by Application (2018-2024) (M Doses)
Table 65. Asia-Pacific Swine Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Swine Vaccines Sales by Application (2018-2024) (M Doses)
Table 67. Latin America Swine Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Swine Vaccines Sales by Application (2018-2024) (M Doses)
Table 69. Middle East and Africa Swine Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Swine Vaccines Sales by Country (2018-2024) & (M Doses)
Table 71. North America Swine Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Swine Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Swine Vaccines Sales Market Share in Value by Country (2018-2024)
Table 74. North America Swine Vaccines Sales by Country (2024-2034) & (M Doses)
Table 75. North America Swine Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Swine Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Swine Vaccines Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Swine Vaccines Sales by Country (2018-2024) & (M Doses)
Table 79. Europe Swine Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Swine Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Swine Vaccines Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Swine Vaccines Sales by Country (2024-2034) & (M Doses)
Table 83. Europe Swine Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Swine Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Swine Vaccines Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Swine Vaccines Sales by Region (2018-2024) & (M Doses)
Table 87. Asia-Pacific Swine Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Swine Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Swine Vaccines Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Swine Vaccines Sales by Region (2024-2034) & (M Doses)
Table 91. Asia-Pacific Swine Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Swine Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Swine Vaccines Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Swine Vaccines Sales by Country (2018-2024) & (M Doses)
Table 95. Latin America Swine Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Swine Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Swine Vaccines Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Swine Vaccines Sales by Country (2024-2034) & (M Doses)
Table 99. Latin America Swine Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Swine Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Swine Vaccines Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Swine Vaccines Sales by Country (2018-2024) & (M Doses)
Table 103. Middle East and Africa Swine Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Swine Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Swine Vaccines Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Swine Vaccines Sales by Country (2024-2034) & (M Doses)
Table 107. Middle East and Africa Swine Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Swine Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Swine Vaccines Sales Market Share in Value by Country (2024-2034)
Table 110. Merck Company Information
Table 111. Merck Introduction and Business Overview
Table 112. Merck Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 113. Merck Swine Vaccines Product
Table 114. Merck Recent Development
Table 115. Boehringer Ingelheim Company Information
Table 116. Boehringer Ingelheim Introduction and Business Overview
Table 117. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 118. Boehringer Ingelheim Swine Vaccines Product
Table 119. Boehringer Ingelheim Recent Development
Table 120. Jinyu Bio-Technology Company Information
Table 121. Jinyu Bio-Technology Introduction and Business Overview
Table 122. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 123. Jinyu Bio-Technology Swine Vaccines Product
Table 124. Jinyu Bio-Technology Recent Development
Table 125. CAHIC Company Information
Table 126. CAHIC Introduction and Business Overview
Table 127. CAHIC Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 128. CAHIC Swine Vaccines Product
Table 129. CAHIC Recent Development
Table 130. Tecon Company Information
Table 131. Tecon Introduction and Business Overview
Table 132. Tecon Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 133. Tecon Swine Vaccines Product
Table 134. Tecon Recent Development
Table 135. Zoetis Company Information
Table 136. Zoetis Introduction and Business Overview
Table 137. Zoetis Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 138. Zoetis Swine Vaccines Product
Table 139. Zoetis Recent Development
Table 140. Ceva Company Information
Table 141. Ceva Introduction and Business Overview
Table 142. Ceva Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 143. Ceva Swine Vaccines Product
Table 144. Ceva Recent Development
Table 145. Hile Bio Company Information
Table 146. Hile Bio Introduction and Business Overview
Table 147. Hile Bio Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 148. Hile Bio Swine Vaccines Product
Table 149. Hile Bio Recent Development
Table 150. Chopper Biology Company Information
Table 151. Chopper Biology Introduction and Business Overview
Table 152. Chopper Biology Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 153. Chopper Biology Swine Vaccines Product
Table 154. Chopper Biology Recent Development
Table 155. WINSUN Company Information
Table 156. WINSUN Introduction and Business Overview
Table 157. WINSUN Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 158. WINSUN Swine Vaccines Product
Table 159. WINSUN Recent Development
Table 160. Hipra Company Information
Table 161. Hipra Introduction and Business Overview
Table 162. Hipra Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 163. Hipra Swine Vaccines Product
Table 164. Hipra Recent Development
Table 165. Ringpu Biology Company Information
Table 166. Ringpu Biology Introduction and Business Overview
Table 167. Ringpu Biology Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 168. Ringpu Biology Swine Vaccines Product
Table 169. Ringpu Biology Recent Development
Table 170. ChengDu Tecbond Company Information
Table 171. ChengDu Tecbond Introduction and Business Overview
Table 172. ChengDu Tecbond Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 173. ChengDu Tecbond Swine Vaccines Product
Table 174. ChengDu Tecbond Recent Development
Table 175. DHN Company Information
Table 176. DHN Introduction and Business Overview
Table 177. DHN Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 178. DHN Swine Vaccines Product
Table 179. DHN Recent Development
Table 180. CAVAC Company Information
Table 181. CAVAC Introduction and Business Overview
Table 182. CAVAC Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 183. CAVAC Swine Vaccines Product
Table 184. CAVAC Recent Development
Table 185. Virbac Company Information
Table 186. Virbac Introduction and Business Overview
Table 187. Virbac Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 188. Virbac Swine Vaccines Product
Table 189. Virbac Recent Development
Table 190. HVRI Company Information
Table 191. HVRI Introduction and Business Overview
Table 192. HVRI Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 193. HVRI Swine Vaccines Product
Table 194. HVRI Recent Development
Table 195. Bioveta Company Information
Table 196. Bioveta Introduction and Business Overview
Table 197. Bioveta Swine Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 198. Bioveta Swine Vaccines Product
Table 199. Bioveta Recent Development
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Swine Vaccines Market Trends
Table 203. Swine Vaccines Market Drivers
Table 204. Swine Vaccines Market Challenges
Table 205. Swine Vaccines Market Restraints
Table 206. Swine Vaccines Distributors List
Table 207. Swine Vaccines Downstream Customers
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Swine Vaccines Product Picture
Figure 2. Global Swine Vaccines Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Swine Vaccines Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Swine Vaccines Sales Status and Outlook (2018-2034) & (M Doses)
Figure 5. Product Picture of CSF Vaccines
Figure 6. Global CSF Vaccines Sales YoY Growth (2018-2034) & (M Doses)
Figure 7. Product Picture of FMD Vaccines
Figure 8. Global FMD Vaccines Sales YoY Growth (2018-2034) & (M Doses)
Figure 9. Product Picture of Porcine Circovirus Vaccines
Figure 10. Global Porcine Circovirus Vaccines Sales YoY Growth (2018-2034) & (M Doses)
Figure 11. Product Picture of PRRS Vaccines
Figure 12. Global PRRS Vaccines Sales YoY Growth (2018-2034) & (M Doses)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (M Doses)
Figure 15. Global Swine Vaccines Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Swine Vaccines Sales Market Share by Type in 2022 & 2034
Figure 17. North America Swine Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. North America Swine Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Europe Swine Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Europe Swine Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Swine Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Swine Vaccines Sales Market Share in Value by Type in 2022
Figure 23. Latin America Swine Vaccines Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Swine Vaccines Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Swine Vaccines Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Swine Vaccines Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Vaccines Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Vaccines Revenue in 2022
Figure 29. Swine Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Government Tender
Figure 31. Global Government Tender Sales YoY Growth (2018-2034) & (M Doses)
Figure 32. Product Picture of Market Sales
Figure 33. Global Market Sales Sales YoY Growth (2018-2034) & (M Doses)
Figure 34. Global Swine Vaccines Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Swine Vaccines Sales Market Share by Application in 2022 & 2034
Figure 36. North America Swine Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. North America Swine Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Europe Swine Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. Europe Swine Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Swine Vaccines Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Swine Vaccines Sales Market Share in Value by Application in 2022
Figure 42. Latin America Swine Vaccines Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Swine Vaccines Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Swine Vaccines Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Swine Vaccines Manufacturing Cost Structure
Figure 47. Swine Vaccines Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed